Full-Time

Scientist I/II

Analytical Development

Posted on 7/30/2024

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

No salary listed

Senior, Expert

Cambridge, MA, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • BS (+8 years experience ), MS (+6 years experience ), or PhD (+2 years experience) in analytical chemistry, biochemistry, chemical engineering, biophysics, or related discipline
  • Expertise in nucleic acid characterization (HPLC/UPLC, LC-MS/MS, CE, UV-Vis)
  • Strong background in analytical method development, particularly chromatography
  • Experience with lipid/LNP characterization methods is a plus (LC-CAD, NTA, CE)
  • Proven ability to work both independently and on cross-functional teams in a fast-paced, entrepreneurial environment
  • Ability to troubleshoot complex problems
  • Highly self-motivated and comfortable delivering against challenging commitments
  • Excellent organizational and communication skills
Responsibilities
  • Design and optimize novel methods to characterize the structure and function of nucleic acid LNPs
  • Develop approaches to separate and identify small molecule/lipid components from complex mixtures
  • Provide technical guidance and hands on support for method development and characterization
  • Collaborate closely with cross-functional teams to support research, formulation, and process development efforts
  • Develop internal and external testing strategies and manage relationships with CROs
  • Author and review SOPs for analytical methods, protocols, technical documents, and reports

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.5B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery complements Flagship's ventures in AI and robotics.
  • Synthetic biology aligns with Flagship's focus on transformative biological innovations.
  • Digital health platforms support Flagship's ventures in remote health technologies.

What critics are saying

  • Increased competition in AI-driven scientific discovery may reduce differentiation.
  • Potential overvaluation in agtech could lead to market corrections and instability.
  • Dependence on academic collaborations may risk if expected advancements aren't achieved.

What makes Flagship Pioneering unique

  • Flagship Pioneering systematically creates first-in-category companies in health and sustainability.
  • The firm combines innovative capacity with entrepreneurial leadership and capital management.
  • Flagship's evolutionary methodology transforms unreasonable propositions into transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

GlobeNewswire
Mar 19th, 2025
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in...

BioPharmaTrend
Mar 11th, 2025
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery.

PR Newswire
Mar 10th, 2025
Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company building the world's first scientific...

ABL Advisor
Mar 3rd, 2025
Trinity Capital Expands Life Sciences Presence to East Coast, Appoints Orlando as Managing Director

Trinity Capital announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston.

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

INACTIVE